|
1
|
March WA, Moore VM, Willson KJ, Phillips
DI, Norman RJ and Davies MJ: The prevalence of polycystic ovary
syndrome in a community sample assessed under contrasting
diagnostic criteria. Hum Reprod. 25:544–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nasiri Amiri F, Ramezani Tehrani F, Simbar
M, Montazeri A and Mohammadpour Thamtan RA: The experience of women
affected by polycystic ovary syndrome: A qualitative study from
Iran. Int J Endocrinol Metab. 12:e136122014.PubMed/NCBI
|
|
3
|
Hung JH, Hu LY, Tsai SJ, et al: Risk of
psychiatric disorders following polycystic ovary syndrome: A
nationwide population-based cohort study. PLoS One. 9:e970412014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ezeh U, Pall M, Mathur R and Azziz R:
Association of fat to lean mass ratio with metabolic dysfunction in
women with polycystic ovary syndrome. Hum Reprod. 29:1508–1517. May
9–2014.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Diamanti-Kandarakis E, Spritzer PM,
Sir-Petermann T and Motta AB: Insulin resistance and polycystic
ovary syndrome through life. Curr Parm Des. 18:5569–5576. 2012.
View Article : Google Scholar
|
|
6
|
Wiltgen D and Spritzer PM: Variation in
metabolic and cardiovascular risk in women with different
polycystic ovary syndrome phenotypes. Fertil Steril. 94:2493–2496.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di Domenico K, Wiltgen D, Nickel FJ,
Magalhães JA, Moraes RS and Spritzer PM: Cardiac autonomic
modulation in polycystic ovary syndrome: Does the phenotype matter?
Fertil Steril. 99:286–292. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pinola P, Lashen H, Bloigu A, et al:
Menstrual disorders in adolescence: A marker for hyperandrogenaemia
and increased metabolic risks in later life? Finnish general
populationbased birth cohort study. Hum Reprod. 27:3279–3286. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Legro RS: The current status for metformin
use in reproductive medicineReproductive Endocrinology and
Infertility. Springer; New York: pp. 183–pp189. 2010, View Article : Google Scholar
|
|
10
|
Lai L, Flower A, Moore M and Lewith G:
Chinese herbal medicine and polycystic ovary syndrome: A randomized
feasibility and pilot study in the United kingdom. J Altern
Complement Med. 20:A61–A62. 2014. View Article : Google Scholar
|
|
11
|
Lai L, Li X, Flower A, et al: Chinese
herbal medicine for oligomenorrhoea and amenorrhoea in polycystic
ovary syndrome: A systematic review and meta-analysis. J Altern
Complement Med. 20:A1292014. View Article : Google Scholar
|
|
12
|
Ma RJ, Zhou J, Fang JQ, Yang DH and Qu F:
Combination of acupuncture and chinese medicinal herbs in treating
model rats with polycystic ovary syndrome. Afr J Tradit Complement
Altern Med. 8:353–361. 2011.PubMed/NCBI
|
|
13
|
Zhang J, Li T, Zhou L, et al: Chinese
herbal medicine for subfertile women with polycystic ovarian
syndrome. Cochrane Database Syst Rev. 8:CD0075352010.
|
|
14
|
Raja-Khan N, Stener-Victorin E, Wu X and
Legro RS: The physiological basis of complementary and alternative
medicines for polycystic ovary syndrome. Am J Physiol Endocrinol
Metab. 301:E1–E10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bargiota A and Diamanti-Kandarakis E: The
effects of old, new and emerging medicine on metabolic aberration
in PCOS. Ther Adv Endocrinol Metab. 3:27–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ladson G, Dodson WC, Sweet SD, et al: The
effects of metformin with lifestyle therapy in polycystic ovary
syndrome: A randomized double-blind study. Fertil Steril.
95:1059–1066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Diamanti-Kandarakis E, Christakou CD,
Kandaraki E and Economou FN: Metformin: An old medication of new
fashion: Evolving new molecular mechanisms and clinical
implications in polycystic ovary syndrome. Eur J Endocrinol.
162:193–212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Palomba S, Falbo A, Russo T, Orio F,
Tolino A and Zullo F: Systemic and local effects of metformin
administration in patients with polycystic ovary syndrome (PCOS):
Relationship to the ovulatory response. Hum Reprod. 25:1005–1013.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Committee for the Update of the Guide for
the Care and Use of Laboratory Animals, . Institute for Laboratory
Animal Research; Division on Earth and Life Studies; National
Research Council: Guide For The Care And Use Of Laboratory Animals.
8th. National Academies Press; Washington, D.C.: 2011
|
|
20
|
Singh KB: Persistent estrus rat models of
polycystic ovary disease: An update. Fertil Steril. 84 (Suppl
2):1228–1234. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goldman JM, Murr AS and Cooper RL: The
rodent estrous cycle: Characterization of vaginal cytology and its
utility in toxicological studies. Birth Defects Res B Dev Reprod
Toxicol. 80:84–97. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cora MC, Kooistra L and Travlos G: Vaginal
Cytology of the Laboratory Rat and Mouse: Review and Criteria for
the Staging of the Estrous Cycle Using Stained Vaginal Smears.
Toxicol Pathol. Mar 3–2015.(Epub ahead of print). doi:
10.1177/0192623315570339. View Article : Google Scholar
|
|
23
|
Sharma ST and Nestler JE: Prevention of
diabetes and cardiovascular disease in women with PCOS: Treatment
with insulin sensitizers. Best Pract Res Clin Endocrinol Metab.
20:245–260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Smith JW and Taylor JS: Polycystic ovary
syndrome: Evidence-based strategies for managing symptoms and
preventing long-term sequelae. Nurs Womens Health. 15:402–410.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mani H, Potdar N and Gleeson H: How to
manage an adolescent girl presenting with features of polycystic
ovary syndrome (PCOS); an exemplar for adolescent health care in
endocrinology. Clin Endocrinol (Oxf). 81:652–656. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Auble B, Elder D, Gross A and Hillman JB:
Differences in the management of adolescents with polycystic ovary
syndrome across pediatric specialties. J Pediatr Adolesc Gynecol.
26:234–238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Chen Y, Yan LY and Qiao J: Increased
expression of P450scc and CYP17 in development of endogenous
hyperandrogenism in a rat model of PCOS. Endocrine. 43:184–190.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng XY, Peng Y, Ren DQ, et al: State
Pharmacopoeia Commission of the People's Republic of China:
Pharmacopoeia of the People's Republic of China (English edition
2000). 1. Chemical Industry Press; pp. 411Beijing, China: 2000
|
|
29
|
Gou YL, Ho AL, Rowlands DK, Chung YW and
Chan HC: Effects of Bak Foong Pill on blood coagulation and
platelet aggregation. Biol Pharm Bull. 26:241–246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rowlands DK, Cui YG, So SC, Tsang LL,
Chung YW and Chan HC: Bak Foong Pills induce an analgesic effect by
inhibiting nociception via the somatostatin pathway in mice. Cell
Biol Int. 36:63–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu W, Zheng X, Qu Z, et al: Effects of
935-Mhz phone-simulating electromagnetic radiation on endometrial
glandular cells during mouse embryo implantation. J Huazhong Univ
Sci Technolog Med Sci. 32:755–759. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rowlands DK, Cui YG, Wong HY, Gou YL and
Chan HC: Traditional Chinese medicine Bak Foong Pills alters
uterine quiescence-possible role in alleviation of dysmenorrhoeal
symptoms. Cell Biol Int. 33:1207–1211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Morciano A, Romani F, Sagnella F, et al:
Assessment of insulin resistance in lean women with polycystic
ovary syndrome. Fertil Steril. 102:250–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stepto NK, Cassar S, Joham AE, et al:
Women with polycystic ovary syndrome have intrinsic insulin
resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod.
28:777–784. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Clirk DA and Dilbaz B: What do we know
about metabolic syndrome in adolescents with PCOS? J Turk Ger
Gynecol Assoc. 15:49–55. 2014. View Article : Google Scholar : PubMed/NCBI
|
